Asim Noor Rana

Asim Noor Rana

Auto-generated profile, based on publicly available information

Asim Noor Rana

Department of Pediatric Hematology and Oncology, Dubai Hospital, Dubai,United Arab Emirates

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2020 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
RKRejin Kebudi
Rejin Kebudi
NANisreen Amayiri
Nisreen Amayiri
MAMalak Abedalthagafi
Malak Abedalthagafi
ARAsım Noor Rana
Asım Noor Rana
SKSalman Kirmani
Salman Kirmani
FPfor the International RRD Consortium on Low‐Resource Settings Panel
for the International RRD Consortium on Low‐Resource Settings Panel

1 January 2006 in Pediatric Hematology and Oncology
Verified
Journal Article
Closed access
ARAsim Noor Rana
Asim Noor Rana
AQAsim Qidwai
Asim Qidwai
JPJon Pritchard
Jon Pritchard
MAM. Shamvil Ashraf
M. Shamvil Ashraf
We report the case of a girl with multi-focal hepatoblastoma in whom chemotherapy alone has resulted in long term event-free survival and possibly cure, without any surgical procedure apart from biopsy for initial diagnosis. At presentation she had a large tumour arising from the left lobe of liver and two other separate masses were noted in the right lobe, but the lungs were free of metastases. Histology showed a foetal type of hepatoblastoma. The serum alpha-feto protein (AFP) level was 44,000 iu/litre. Chemotherapy was started using the triple drug regime recommended for “high risk” (of relapse) patients in the SIOPEL 2 hepatoblastoma protocol of the International Society of Paedaitric Oncology (SIOP). Within a few weeks her abdominal girth decreased, the child became much more comfortable. Drug-induced cardiotoxicity, ototoxicity and nephrotoxicity were not observed. After a total of 4 courses of chemotherapy (completed at the end of August 1998) a CT scan showed that all 3 tumours were smaller but that there were residual multifocal defects in the liver neither hepatic resection nor liver transplantation were considered safe or appropriate. 6.5 years after completion of chemotherapy and now aged 8.5 years the child is in normal health and at school with normal liver size, serum AFP levels and chest imaging.

28 January 2020 in Dubai Medical Journal
Verified
Journal Article
Open access
PDF file
ARAsim Noor Rana
Asim Noor Rana
HHHani Humad
Hani Humad
AAAeman Muhammad Asif
Aeman Muhammad Asif
DGDana Ghannam
Dana Ghannam
NNNadia Nadeem
Nadia Nadeem
We herein report a rare case of malignant mixed germ cell tumor comprising both an embryonal carcinoma (60%) and a yolk sac tumor (40%). A 7-year-old girl presented to the emergency department with persistent vaginal bleeding, abdominal pain, and vomiting. A CT scan of the pelvis and abdomen revealed a huge pelvic mass, 16 × 16 × 8 cm, arising from the left ovary and extending into the upper abdomen and displacing bowel loops to the sides. The mass was lobulated and heterogeneously enhancing. Initial investi­gations revealed raised values of beta-human chorionic gonadotrophin (B-hCG) and alpha-fetoprotein (AFP). She underwent a laparotomy and a left salphingo-oophorectomy. Histopathology of the excised mass revealed a malignant mixed germ cell tumor comprising both an embryonal carcinoma (60%) and a yolk sac tumor (40%). Following surgery, she was started on adjuvant chemotherapy based on the MAKEI 96 protocol and was given 4 cycles of PEI chemotherapy (cisplatin, etoposide, and ifosfamide). Multidisciplinary team management consisting of careful initial surgery with adequate staging biopsies followed by combination chemotherapy and endocrinological evaluation and treatment can greatly improve the prognosis of these patients.

26 October 2015 in Case Reports in Hematology
Verified
Journal Article
Open access
PDF file
AMAnjan Madasu
Anjan Madasu
ARAsim Noor Rana
Asim Noor Rana
SBSaleh Banat
Saleh Banat
HHHani Humad
Hani Humad
RMRashid Mustafa
Rashid Mustafa
AAAbdulrahman Mohd AlJassmi
Abdulrahman Mohd AlJassmi
Langerhans cell histiocytosis (LCH) is a rare disorder characterized by proliferation and accumulation of clonal dendritic cells with varied clinical presentation and an unpredictable course. We report a 5-month-old infant with LCH who presented with severe respiratory distress, a large mediastinal mass, significant generalized lymphadenopathy, and hepatosplenomegaly. Lymphoma, especially T cell lymphoblastic lymphoma, can present with superior mediastinal syndrome needing urgent empirical therapy without biopsy. However, lack of response prompted a biopsy which confirmed it to be a case of LCH and that leads to appropriate therapy and survival. There have been reports of LCH presenting with isolated mediastinal mass or with generalized lymphadenopathy, but the combined presentation of generalized lymphadenopathy with large mediastinal mass, hepatosplenomegaly, and fever in an infant has rarely been reported. Conclusion. LCH should also be considered in the differential diagnosis of an infant presenting with generalized lymphadenopathy, mediastinal mass, hepatosplenomegaly, and fever. Langerhans cell histiocytosis (LCH) is a rare disorder characterized by proliferation and accumulation of clonal dendritic cells with varied clinical presentation and an unpredictable course. We report a 5-month-old infant with LCH who presented with severe respiratory distress, a large mediastinal mass, significant generalized lymphadenopathy, and hepatosplenomegaly. Lymphoma, especially T cell lymphoblastic lymphoma, can present with superior mediastinal syndrome needing urgent empirical therapy without biopsy. However, lack of response prompted a biopsy which confirmed it to be a case of LCH and that leads to appropriate therapy and survival. There have been reports of LCH presenting with isolated mediastinal mass or with generalized lymphadenopathy, but the combined presentation of generalized lymphadenopathy with large mediastinal mass, hepatosplenomegaly, and fever in an infant has rarely been reported. Conclusion. LCH should also be considered in the differential diagnosis of an infant presenting with generalized lymphadenopathy, mediastinal mass, hepatosplenomegaly, and fever.

1 January 2021 in New Emirates Medical Journal
Verified
Journal Article
Open access
PDF file
AAAbdulrahman Mohammad AlJassmi
Abdulrahman Mohammad AlJassmi
ARAsim Noor Rana
Asim Noor Rana
HHHani Humad
Hani Humad
AMAnjan Madasu
Anjan Madasu
Background: Wilms Tumor (WT) is the most common pediatric kidney tumor, yet the disease has variable clinical characteristics and prognostic outcomes across different populations. Objectives: This study aims to review the clinical characteristics and survival outcomes of children with WT who have received treatment at Dubai Hospital, UAE. Methods: A retrospective study was conducted involving the medical records of confirmed WT children (aged < 14 years) who had received treatment between 2013 and 2018. Diagnosis should have been established based on the histopathological examination of operable tumors and needle biopsy for inoperable tumors. The Société Internationale d’Oncologie Pédiatrique (SIOP) WT 2001 protocol was used for patient management, and the UMBRELLA SIOP–RTSG 2016 Wilms tumor pathology and molecular biology protocol was used for histopathologic classification and clinical staging. The presenting sign and symptoms, the findings of diagnostic imaging techniques, histological grading, the received treatments, and follow-up outcomes were collected and analyzed. Kaplan-Meier survival analysis was used to carry out the survival analysis. Results: Ten children were diagnosed with WT (median age of 3.40 years, 60% males). All patients presented with abdominal masses without prominent pain. Synchronous bilateral lesions were found at diagnosis in one patient and metastatic lesions in three patients. Four children were discharged against medical advice; five received treatment according to the SIOP WT 2001 regimen, while the remaining patient was managed in the United States according to the National Wilms Tumor Study Group (NWTSG) protocol. The overall 6-year and relapse-free survival rates were 90% and 80%, respectively. Conclusion: The clinical characteristics and managemental outcomes of children presenting with WT are promising, possibly owing to adopting the SIOP protocol. Considering the small sample size, more large-scale, nation-wide studies are warranted.

12 June 2019 in Dubai Medical Journal
Verified
Journal Article
Open access
PDF file
AAAbdulrahman Mohammad AlJassmi
Abdulrahman Mohammad AlJassmi
ARAsim Noor Rana
Asim Noor Rana
HHHani Humad
Hani Humad
AMAnjan Madasu
Anjan Madasu
SKShoaib Shahzad Khan
Shoaib Shahzad Khan
Introduction: Shwachman-Diamond syndrome is a rare genetic disease that presents with bone marrow failure, exocrine pancreatic insufficiency, and metaphyseal chondrodysplasia in infancy. Case Report: This report describes a 2.5-month-old boy who presented with a chief complaint of blocked nasal passages. His other part of the history was otherwise unremarkable. However, on examination, he was pale, a systolic ejection murmur was auscultated on the left parasternal border, and the tips of the spleen and liver were palpated on abdominal examination. His workup indicated persistent anemia and neutropenia in the setting of normal platelet and white blood cell count despite multiple transfusions with packed red blood cells. Further workup revealed normal size and function of all organs but the pancreas, with low amylase and lipase being noted. On follow-up, he was reported to have fatty stools, which were confirmed with an elevated stool fat, and congenital bone marrow failure confirmed by a bone marrow aspirate and flow cytometry. Whole exome sequencing indicated a genetic mutation that is diagnostic of Shwachman-Diamond syndrome. Conclusion: Shwachman-Diamond syndrome is a rare entity. However, a presentation of hematologic abnormalities especially neutropenia and anemia with bone marrow failure, skeletal abnormalities, pancreatic exocrine insufficiency, and any other organ involvement in infancy should prompt the clinician to develop a high index of suspicion for the disease.